Peg Esper

2.2k total citations · 1 hit paper
30 papers, 1.8k citations indexed

About

Peg Esper is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Peg Esper has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Peg Esper's work include Cancer survivorship and care (6 papers), Palliative Care and End-of-Life Issues (6 papers) and Renal cell carcinoma treatment (4 papers). Peg Esper is often cited by papers focused on Cancer survivorship and care (6 papers), Palliative Care and End-of-Life Issues (6 papers) and Renal cell carcinoma treatment (4 papers). Peg Esper collaborates with scholars based in United States, Spain and Canada. Peg Esper's co-authors include Kenneth J. Pienta, Bruce G. Redman, Gerald W. Chodak, David Cella, Michael Sinner, Fei Mo, Peter C. Trask, David C. Smith, Michelle Riba and Martha Polovich and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of the American Academy of Dermatology.

In The Last Decade

Peg Esper

29 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument

1997 565 citations Peg Esper, Fei Mo et al. Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peg Esper United States	18	757	702	219	205	186	30	1.8k
K. Sundquist United States	22	484 0.6×	575 0.8×	223 1.0×	171 0.8×	172 0.9×	45	1.9k
August Zabernigg Austria	22	684 0.9×	401 0.6×	153 0.7×	141 0.7×	127 0.7×	57	1.6k
Carolyn J. Presley United States	24	1.2k 1.6×	566 0.8×	167 0.8×	162 0.8×	167 0.9×	150	2.0k
Laura Giordano Italy	31	982 1.3×	873 1.2×	246 1.1×	305 1.5×	387 2.1×	165	3.3k
David Wyld Australia	24	1.2k 1.5×	423 0.6×	261 1.2×	201 1.0×	225 1.2×	127	2.1k
Sherri L. Stewart United States	27	992 1.3×	410 0.6×	225 1.0×	406 2.0×	233 1.3×	79	2.3k
E. Franssen Canada	17	759 1.0×	495 0.7×	194 0.9×	287 1.4×	140 0.8×	35	1.9k
Larry F. Ellison Canada	21	624 0.8×	340 0.5×	197 0.9×	201 1.0×	151 0.8×	47	1.7k
Åsa Klint Sweden	26	1.1k 1.5×	464 0.7×	121 0.6×	360 1.8×	183 1.0×	34	2.3k
Reda Wilson United States	20	985 1.3×	460 0.7×	219 1.0×	258 1.3×	422 2.3×	42	2.3k

Countries citing papers authored by Peg Esper

Since Specialization

Citations

This map shows the geographic impact of Peg Esper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peg Esper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peg Esper more than expected).

Fields of papers citing papers by Peg Esper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peg Esper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peg Esper. The network helps show where Peg Esper may publish in the future.

Co-authorship network of co-authors of Peg Esper

This figure shows the co-authorship network connecting the top 25 collaborators of Peg Esper. A scholar is included among the top collaborators of Peg Esper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peg Esper. Peg Esper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Esper, Peg, et al.. (2016). Early Recognition and Management of Posterior Reversible Encephalopathy Syndrome: A Newly Recognized Complication in Patients Receiving Tyrosine Kinase Inhibitors. Clinical journal of oncology nursing. 20(3). 305–308. 3 indexed citations

Stenehjem, David D., Michael Toole, Joseph A. Merriman, et al.. (2016). Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2. Cancer Immunology Immunotherapy. 65(8). 941–949. 14 indexed citations

Esper, Peg, et al.. (2014). Improving documentation of quality measures in the electronic health record. Journal of the American Association of Nurse Practitioners. 27(6). 308–312. 15 indexed citations

Esper, Peg. (2013). Identifying Strategies to Optimize Care With Oral Cancer Therapy. Clinical journal of oncology nursing. 17(6). 629–636. 9 indexed citations

Neuss, Michael N., Martha Polovich, Kristen K. McNiff, et al.. (2013). 2013 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards Including Standards for the Safe Administration and Management of Oral Chemotherapy. Oncology nursing forum. 40(3). 225–233. 61 indexed citations

Esper, Peg. (2012). Concepts in Advanced Renal Carcinoma. Seminars in Oncology Nursing. 28(3). 170–179. 6 indexed citations

Jacobson, Joseph O., Martha Polovich, Terry Gilmore, et al.. (2011). Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards: Expanding the Scope to Include Inpatient Settings. Oncology nursing forum. 39(1). 31–38. 25 indexed citations

Esper, Peg. (2010). Symptom Clusters in Individuals Living With Advanced Cancer. Seminars in Oncology Nursing. 26(3). 168–174. 21 indexed citations

Redman, Bruce G., Alfred E. Chang, Joel Whitfield, et al.. (2008). Phase Ib Trial Assessing Autologous, Tumor-pulsed Dendritic Cells as a Vaccine Administered With or Without IL-2 in Patients With Metastatic Melanoma. Journal of Immunotherapy. 31(6). 591–598. 67 indexed citations

10.

Esper, Peg, et al.. (2007). What Kind of Rash Is It?: Deciphering the Dermatologic Toxicities of Biologic and Targeted Therapies. Clinical journal of oncology nursing. 11(5). 659–666. 16 indexed citations

11.

Esper, Peg, et al.. (2005). Symptom clusters in advanced illness. Seminars in Oncology Nursing. 21(1). 20–28. 37 indexed citations

12.

Paterson, Amber G., Peter C. Trask, Lynne I. Wagner, Peg Esper, & Bruce G. Redman. (2005). Validation of the FACT-BRM with interferon-α treated melanoma patients. Quality of Life Research. 14(1). 133–139. 10 indexed citations

13.

Smith, David C., Christopher H. Chay, Rodney L. Dunn, et al.. (2003). Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone‐refractory prostate carcinoma. Cancer. 98(2). 269–276. 30 indexed citations

14.

Lowe, Lori, Bruce G. Redman, Peg Esper, et al.. (2003). Placental metastasis of maternal melanoma. Journal of the American Academy of Dermatology. 49(6). 1150–1154. 53 indexed citations

15.

Trask, Peter C., et al.. (2003). Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon. Psycho-Oncology. 13(8). 526–536. 49 indexed citations

16.

Hellerstedt, Beth A., Kenneth J. Pienta, Bruce G. Redman, et al.. (2003). Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen‐independent prostate carcinoma. Cancer. 98(8). 1603–1610. 28 indexed citations

17.

Esper, Peg, et al.. (2002). Palliative practices from A-Z for the bedside clinician. 2 indexed citations

18.

Esper, Peg, et al.. (2002). Strengthening end-of-life care through specialty nursing certification. Journal of Professional Nursing. 18(3). 130–139. 3 indexed citations

19.

Esper, Peg & Bruce G. Redman. (1999). SUPPORTIVE CARE, PAIN MANAGEMENT, AND QUALITY OF LIFE IN ADVANCED PROSTATE CANCER. Urologic Clinics of North America. 26(2). 375–389. 28 indexed citations

20.

Esper, Peg, Fei Mo, Gerald W. Chodak, et al.. (1997). Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument. Urology. 50(6). 920–928. 565 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact